Skip to main content
FinSpry Logo
FinSpry
KZIA logo
KZIA
(NASDAQ)
Kazia Therapeutics Limited
$13.04-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kazia Therapeutics (KZIA) Stock Price & Financial Analysis

Kazia Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.51 - $14.69
52-Week High$17.40
52-Week Low$4.86
Open$14.55
Volume381.38K
Average Volume (3M)172.43K
Market Cap40.69M
Shares Outstanding3.12M
Price to Sales (P/S)23.08
Price to Book (P/B)1.25
EV/EBITDA0.25
Revenue (TTM)1.76M
Net Income (TTM)-35.41M
Free Cash Flow (TTM)-17.34M
EPS (TTM)$-23.22
Profit Margin-2008.78%
Operating Margin-1866.72%
Return on Equity (ROE)-109.07%
Debt to Equity0.00
50-Day MA$13.18
200-Day MA$9.60
52-Week Change26.91%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJan 28, 2013

Frequently Asked Questions About Kazia Therapeutics

What is the current stock price for KZIA?

As of the latest trading session, KZIA stock trades at $13.04. The 52-week range is $4.86–$17.40, with a day range of $12.51–$14.69.

What is the P/E ratio for KZIA?

The P/E ratio (Price-to-Earnings) for KZIA is shown in the Key Statistics section. This valuation metric helps compare Kazia Therapeutics Limited to industry peers.

Does KZIA pay dividends?

Kazia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KZIA?

Based on 4 analysts, the consensus for KZIA is Buy.

What is the market cap of KZIA?

Kazia Therapeutics's market capitalization is $40.7M, classifying it as a micro-cap company. Kazia Therapeutics operates in the Healthcare sector within the Biotechnology industry.